Camptothecins in Cancer Therapy

Clinical interest in the camptothecins continues to expand even though this class of topoisomerase I inhibitors has been studied for almost 50 years, and two early generation members of the family have gained FDA approval. In Camptothecins in Cancer Therapy, leading clinicians and researchers critic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor corporatiu: SpringerLink (Online service)
Altres autors: Adams, Val R. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electrònic eBook
Idioma:English
Publicat: Totowa, NJ : Humana Press : Imprint: Humana, 2005.
Edició:1st ed. 2005.
Periòdiques:Cancer Drug Discovery and Development,
Matèries:
Accés en línia:https://doi.org/10.1385/1592598668
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!